Eloxx Pharmaceuticals Inc (ELOX) has gained 27.97% Wednesday In Premarket Trading

Wednesday, July 12, 2023 06:47 AM | InvestorsObserver Analysts

Mentioned in this article

Eloxx Pharmaceuticals Inc (ELOX) has gained 27.97% Wednesday In Premarket Trading

Eloxx Pharmaceuticals Inc (ELOX) has risen Wednesday morning, with the stock increasing 27.97% in pre-market trading to 9.7. ELOX's short-term technical score of 76 indicates that the stock has traded more bullishly over the last month than 76% of stocks on the market. In the Biotechnology industry, which ranks 122 out of 146 industries, the stock ranks higher than 87% of stocks. Eloxx Pharmaceuticals Inc has risen 29.79% over the past month, closing at $6.98 on June 14. During this period of time, the stock fell as low as $3.61 and as high as $7.58. ELOX has an average analyst recommendation of Strong Buy. The company has an average price target of $50.00.

ELOX has an Overall Score of 79. Find out what this means to you and get the rest of the rankings on ELOX!

See Full ELOX Report

Eloxx Pharmaceuticals Inc has a Long-Term Technical rank of 85. This means that trading over the last 200 trading days has placed the company in the upper half of stocks with 15% of the market scoring higher. In the Biotechnology industry which is number 117 by this metric, ELOX ranks better than 117% of stocks.

Important Dates for Investors in ELOX:

-Eloxx Pharmaceuticals Inc is set to release earnings on 8/21/2023. Over the last 12 months, the company has reported EPS of $-19.74. -We do not have a set dividend date for Eloxx Pharmaceuticals Inc at this time. Click Here To Get The Full Report on Eloxx Pharmaceuticals Inc (ELOX)